Effects of Oregano ( Origanum vulgare ) Essential Oil Supplementation on Growth Performance of Zebrafish ( Danio rerio ) Fed a High-Inclusion Soybean Meal Diet
Zebrafish · 01.10.2024 · 21 (5) · 338-348
DOI: 10.1089/zeb.2024.0139 ↗Kurz gefasst
Fachartikel in der Zeitschrift Zebrafish, erschienen am 01.10.2024. Verfasst von Aubrey Dissinger und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, University of New Hampshire, Durham, New Hampshire, USA. Hauptthemen laut MEDLINE: Zebrafish, Origanum, Oils, Volatile, Animal Feed. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 79 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, University of New Hampshire, Durham, New Hampshire, USA.
- Department of Zoology, Southern Illinois University - Carbondale, Carbondale, Illinois, USA.
- Department of Biological Sciences, University of Idaho, Moscow, Idaho, USA.
Zitieren
APA
Dissinger, A., Bowman, J., Molinari, G. S., & Kwasek, K. (2024). Effects of Oregano ( Origanum vulgare ) Essential Oil Supplementation on Growth Performance of Zebrafish ( Danio rerio ) Fed a High-Inclusion Soybean Meal Diet. Zebrafish, 21(5), 338-348. https://doi.org/10.1089/zeb.2024.0139
Vancouver
Dissinger A, Bowman J, Molinari GS, Kwasek K. Effects of Oregano ( Origanum vulgare ) Essential Oil Supplementation on Growth Performance of Zebrafish ( Danio rerio ) Fed a High-Inclusion Soybean Meal Diet. Zebrafish. 2024;21(5):338-348. doi:10.1089/zeb.2024.0139
BibTeX
@article{Dissinger2024,
author = {Dissinger, Aubrey and Bowman, Jacob and Molinari, Giovanni S and Kwasek, Karolina},
title = {Effects of Oregano ( Origanum vulgare ) Essential Oil Supplementation on Growth Performance of Zebrafish ( Danio rerio ) Fed a High-Inclusion Soybean Meal Diet},
journal = {Zebrafish},
year = {2024},
volume = {21},
number = {5},
pages = {338--348},
doi = {10.1089/zeb.2024.0139}
}
EUVIMED